Amylyx is a clinical-stage biopharmaceutical company dedicated to treating diseases with high unmet needs, including post-bariatric hypoglycemia, Wolfram syndrome, and ALS. They have assembled an experienced team with a culture of caring, guided by core values of audacity, curiosity, authenticity, engagement, and accountability.